Amy A. Kirkwood - Concepedia

Author

Amy A. Kirkwood

Also Known As

A A Kirkwood, A Kirkwood, A. A Kirkwood, A. A. Kirkwood, A. Kirkwood, A.A. Kirkwood, Amy A Kirkwood, Amy A. Kirkwood, Amy Kirkwood, Johnson, Peter

188

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

University College London Cancer Research UK CRUK Lung Cancer Centre of Excellence Nottingham University Hospitals NHS Trust University Hospitals Bristol NHS Foundation Trust

About

Amy A. Kirkwood is an author at University College London specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	1.2K
2	Health Sciences	8	8	652
3	Education	1	1	117
4	Blood Transplantation	1	1	18
5	Cellular Therapies	1	1	18

Amy A. Kirkwood

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma Peter Johnson, Massimo Federico, Amy A. Kirkwood, New England Journal of Medicine	2016	778
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization Roopinder Gillmore, Sam Stuart, Amy A. Kirkwood, Journal of Hepatology Surgical OncologyHepatologyMedicineIndependent Prognostic FactorsLiver Disease	2011	322
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial Peter Hoskin, Amy A. Kirkwood, Bilyana Popova, The Lancet Oncology Lymphoid NeoplasiaSurgical OncologyRadiation TherapyMedicineGy Versus 24	2014	238
Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress Richard Burt, Aditi Dey, Sarah Aref, Blood	2019	229
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours Nicholas C. Turner, Sandra J. Strauss, Debashis Sarker, British Journal of Cancer	2010	193
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study Sally F. Barrington, Amy A. Kirkwood, Antonella Franceschetto, Blood	2016	181
Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors Mohid S. Khan, Amy A. Kirkwood, Theodora Tsigani, Journal of Clinical Oncology	2012	178
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma Tim Meyer, Amy A. Kirkwood, Sandy Beare, British Journal of Cancer	2013	145
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma Claire Roddie, Lorna Neill, Wendy Osborne, Blood Advances	2023	133
Interpreting and reporting clinical trials with results of borderline significance Allan Hackshaw, Amy A. Kirkwood BMJ Borderline SignificanceEpidemiologyMeta-analysisClinical EndpointPatient Safety	2011	117

Page 1